Isolation and Proteomic Analysis of Mouse Serum Small Extracellular Vesicles for Individual Subject Analysis

Federica Anastasi1,2, Marialaura Dilillo2, Davide Pellegrini1,2

  • 1NEST Laboratories, Scuola Normale Superiore, Pisa, Italy.

Insights

We developed a method to analyze proteins from small extracellular vesicles (sEVs) in just 50 μL of mouse serum. This technique enables longitudinal studies of disease progression in rodent models using minimal blood volumes.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Biomedical Research

Background:

  • Circulating small extracellular vesicles (sEVs) are crucial for intercellular communication and are studied for disease monitoring via proteomics.
  • Rodent models are vital for human disease research due to genetic similarities and shorter lifespans.
  • Longitudinal studies in rodents are challenged by limited blood withdrawal volumes (approx. 75 μL serum per sample).

Purpose of the Study:

  • To develop a method for isolating and characterizing serum sEV proteins from small blood volumes (50 μL) for longitudinal studies in mouse models.
  • To enable detailed proteomic profiling of sEVs from limited serum samples, facilitating disease progression research.

Main Methods:

  • Developed a protocol for sEV isolation from 50 μL of mouse serum.
  • Performed morphological characterization of isolated sEVs.
  • Conducted proteome profiling of sEVs using mass spectrometry.

Main Results:

  • Successfully isolated and characterized serum sEVs from a minimal blood volume.
  • Established a method for proteomic analysis of sEVs suitable for longitudinal studies.
  • Provided detailed steps and considerations for sEV isolation, characterization, and proteomic profiling.

Conclusions:

  • The developed approach allows for longitudinal proteomic analysis of serum sEVs in rodent models using significantly reduced blood volumes.
  • This method overcomes a key limitation in rodent studies, enabling more robust research into disease mechanisms and biomarker discovery.
  • The described protocol facilitates minimally invasive, in-depth investigation of sEVs in disease progression and therapeutic monitoring.

Related Concept Videos